Cargando…
Fluorescence-guided imaging for resection margin evaluation in head and neck cancer patients using cetuximab-800CW: A quantitative dose-escalation study
Tumor-positive resection margins are present in up to 23% of head and neck cancer (HNC) surgeries, as intraoperative techniques for real-time evaluation of the resection margins are lacking. In this study, we investigated the safety and potential clinical value of fluorescence-guided imaging (FGI) f...
Autores principales: | Voskuil, Floris Jan, de Jongh, Steven Jakob, Hooghiemstra, Wouter Tjerk Rudolph, Linssen, Matthijs David, Steinkamp, Pieter Jan, de Visscher, Sebastiaan Antonius Hendrik Johannes, Schepman, Kees-Pieter, Elias, Sjoerd Geert, Meersma, Gert-Jan, Jonker, Pascal Klaas Christiaan, Doff, Jan Johannes, Jorritsma-Smit, Annelies, Nagengast, Wouter Bastiaan, van der Vegt, Bert, Robinson, Dominic James, van Dam, Gooitzen Michell, Witjes, Max Johannes Hendrikus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7086353/ https://www.ncbi.nlm.nih.gov/pubmed/32226534 http://dx.doi.org/10.7150/thno.43227 |
Ejemplares similares
-
Fluorescence molecular imaging using cetuximab‐800CW in cutaneous squamous cell carcinoma surgery: a proof‐of‐concept study
por: Vonk, Jasper, et al.
Publicado: (2022) -
A Standardized Framework for Fluorescence-Guided Margin Assessment for Head and Neck Cancer Using a Tumor Acidosis Sensitive Optical Imaging Agent
por: Steinkamp, Pieter Jan, et al.
Publicado: (2021) -
Feasibility of ex vivo fluorescence imaging of angiogenesis in (non-) culprit human carotid atherosclerotic plaques using bevacizumab-800CW
por: Huisman, Lydian A., et al.
Publicado: (2021) -
Development and Characterisation of Antibody-Based Optical Imaging Probes for Inflammatory Bowel Disease
por: Linssen, Matthijs David, et al.
Publicado: (2021) -
EGFR-targeted fluorescence molecular imaging for intraoperative margin assessment in oral cancer patients: a phase II trial
por: de Wit, Jaron G., et al.
Publicado: (2023)